Sex differences in comorbidities associated with Sjögren's disease

Background Little is known about the association of comorbidities with sex and age at diagnosis in Sjögren's disease. We tested the hypothesis that sex differences occur in comorbidities in patients with Sjögren's disease. Methods Patients with Sjögren's disease were identified from 11/1974 to 7/2018 in the Mayo Clinic electronic medical record and assessed for 22 comorbidities according to sex and age at diagnosis. Results Of the 13,849 patients identified with Sjögren's disease, 11,969 (86%) were women and 1,880 (14%) men, primarily white (88%) with a sex ratio of 6.4:1 women to men. The mean age at diagnosis was 57 years for women and 59.7 years for men, and 5.6% had a diagnosis of fibromyalgia at Sjögren's diagnosis. Men with Sjögren's disease were more likely than women to be a current or past smoker. The average time to diagnosis of comorbidities after diagnosis of Sjögren's disease was 2.6 years. The top comorbidities in patients with Sjögren's disease were fibromyalgia (25%), depression (21.2%) and pain (16.4%). Comorbidities that occurred more often in women were hypermobile syndromes (31:1), CREST (29:1), migraine (23:1), Ehlers-Danlos syndrome (EDS) (22:1), Raynaud's syndrome (15:1), SLE (13:1), systemic sclerosis (SSc) (13:1), and fibromyalgia (12:1). Women with Sjögren's disease were at increased risk of developing hypermobile syndromes (RR 7.27, CI 1.00–52.71, p = 0.05), EDS (RR 4.43, CI 1.08–18.14, p = 0.039), CREST (RR 4.24, CI 1.56–11.50, p = 0.005), migraine (RR 3.67, CI 2.39–5.62, p < 0.001), fibromyalgia (RR 2.26, CI 1.92–2.66, p < 0.001), Raynaud's syndrome (RR 2.29, CI 1.77–2.96, p < 0.001), SLE (RR 2.13, CI 1.64–2.76, p < 0.001), and SSc (RR 2.05 CI 1.44–2.92; p < 0.001). In contrast, men with Sjögren's were at increased risk for developing myocardial infarction (RR 0.44, CI 0.35–0.55, p < 0.001), atherosclerosis/CAD (RR 0.44, CI 0.39–0.49, p < 0.001), cardiomyopathy (RR 0.63, CI 0.46–0.86, p = 0.003), stroke (RR 0.66 CI 0.51–0.85, p = 0.001), and congestive heart failure (RR 0.70, CI 0.57–0.85, p < 0.001). Conclusions The top comorbidities in Sjögren's disease were fibromyalgia, depression, and pain. Women with Sjögren's disease had a higher relative risk of developing fibromyalgia, depression, pain, migraine, hypermobile syndrome, EDS and other rheumatic autoimmune diseases. Men with Sjögren's disease had higher risk of developing cardiovascular diseases.

[1]  L. Criswell,et al.  Associations Between Smoking and Primary Sjögren Syndrome Classification Using the Sjögren's International Collaborative Clinical Alliance Cohort , 2021, ACR open rheumatology.

[2]  Namrata Singh,et al.  Clinical and laboratory features of patients with focal lymphocytic sialadenitis on minor salivary gland biopsy for sicca symptoms , 2021, Medicine.

[3]  A. Baer,et al.  Sjögren’s Disease, Not Syndrome , 2021, Arthritis & rheumatology.

[4]  L. Alfredsson,et al.  Cigarette smoking patterns preceding primary Sjögren’s syndrome , 2020, RMD open.

[5]  B. Gerdle,et al.  Ehlers–Danlos Syndrome and Hypermobility Syndrome Compared with Other Common Chronic Pain Diagnoses—A Study from the Swedish Quality Registry for Pain Rehabilitation , 2020, Journal of clinical medicine.

[6]  D. Isenberg,et al.  Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome. , 2019, Rheumatology.

[7]  X. Mariette,et al.  EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies , 2019, Annals of the rheumatic diseases.

[8]  M. Perreault,et al.  Hormonal regulation of circuit function: sex, systems and depression , 2019, Biology of Sex Differences.

[9]  C. Baldini,et al.  Comorbidities (excluding lymphoma) in Sjögren's syndrome. , 2019, Rheumatology.

[10]  E. Matteson,et al.  Association of Smoking and Obesity on the Risk of Developing Primary Sjögren Syndrome: A Population-based Cohort Study , 2019, The Journal of Rheumatology.

[11]  T. Barnetche,et al.  Cardiovascular Morbidity and Mortality in Primary Sjögren's Syndrome: A Systematic Review and Meta‐Analysis , 2020, Arthritis care & research.

[12]  C. Gordon,et al.  The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County , 2019, Arthritis care & research.

[13]  U. Reuter,et al.  Male and female sex hormones in primary headaches , 2018, The Journal of Headache and Pain.

[14]  A. Murphy,et al.  Impact of sex on pain and opioid analgesia: a review , 2018, Current Opinion in Behavioral Sciences.

[15]  C. N. Bairey Merz,et al.  Sex-specific risk factors for cardiovascular disease in women-making cardiovascular disease real , 2018, Current opinion in cardiology.

[16]  G. Guggino,et al.  Cardiovascular Disease in Primary Sjögren's Syndrome. , 2018, Reviews on recent clinical trials.

[17]  Louise D McCullough,et al.  Age and Sex Are Critical Factors in Ischemic Stroke Pathology. , 2018, Endocrinology.

[18]  C. Turesson,et al.  Smoking, disease characteristics and serum cytokine levels in patients with primary Sjögren’s syndrome , 2018, Rheumatology International.

[19]  G. L. La Paglia,et al.  The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren's syndrome. , 2018, Clinical and experimental rheumatology.

[20]  D. Fairweather,et al.  Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease , 2018, Biology of Sex Differences.

[21]  R. Jonsson,et al.  Long-term follow-up in primary Sjögren’s syndrome reveals differences in clinical presentation between female and male patients , 2017, Biology of Sex Differences.

[22]  M. Kvarnström,et al.  Difference in clinical presentation between women and men in incident primary Sjögren’s syndrome , 2017, Biology of Sex Differences.

[23]  C. Turesson,et al.  Cigarette smoking and the risk of primary Sjögren’s syndrome: a nested case control study , 2017, Arthritis Research & Therapy.

[24]  R. Grahame,et al.  Hypermobile Ehlers–Danlos syndrome (a.k.a. Ehlers–Danlos syndrome Type III and Ehlers–Danlos syndrome hypermobility type): Clinical description and natural history , 2017, American journal of medical genetics. Part C, Seminars in medical genetics.

[25]  J. Andreu,et al.  Fibromyalgia prevalence and associated factors in primary Sjögren's syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER). , 2017, Clinical and experimental rheumatology.

[26]  B. Segal,et al.  Effect of Tobacco Smoking on The Clinical, Histopathological, and Serological Manifestations of Sjögren’s Syndrome , 2017, PloS one.

[27]  M. Fernandez Castro,et al.  Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries‐Based Study , 2017, Arthritis care & research.

[28]  E. Matteson,et al.  Prevalence of Primary Sjögren's Syndrome in a US Population‐Based Cohort , 2016, Arthritis care & research.

[29]  J. Birt,et al.  Sjögren's syndrome: managed care data from a large United States population highlight real-world health care burden and lack of treatment options. , 2017, Clinical and experimental rheumatology.

[30]  J. Anaya,et al.  Polyautoimmunity in Sjögren Syndrome. , 2016, Rheumatic diseases clinics of North America.

[31]  Yeong-Wook Song,et al.  Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren's syndrome. , 2016, Clinical and experimental rheumatology.

[32]  R. Priori,et al.  Sex differences in Sjögren’s syndrome: a comprehensive review of immune mechanisms , 2015, Biology of Sex Differences.

[33]  E. Vicenzini,et al.  A study of migraine characteristics in joint hypermobility syndrome a.k.a. Ehlers–Danlos syndrome, hypermobility type , 2015, Neurological Sciences.

[34]  C. Vitali,et al.  Pain in primary Sjögren's syndrome. , 2015, Best practice & research. Clinical rheumatology.

[35]  J. Epstein,et al.  Managing the care of patients with Sjögren syndrome and dry mouth: comorbidities, medication use and dental care considerations. , 2014, Journal of the American Dental Association.

[36]  D. Fairweather.  Sex Differences in Inflammation During Atherosclerosis , 2014, Clinical Medicine Insights. Cardiology.

[37]  L. Cooper,et al.  Sex and gender differences in myocarditis and dilated cardiomyopathy. , 2013, Current problems in cardiology.

[38]  M. Cook,et al.  Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. , 2012, Autoimmunity reviews.

[39]  L. Criswell,et al.  Primary Sjögren's syndrome as a systemic disease: A study of participants enrolled in an International Sjögren's syndrome registry , 2012, Arthritis care & research.

[40]  A. M. Azzarolo,et al.  Influence of sex hormones and genetic predisposition in Sjögren's syndrome: a new clue to the immunopathogenesis of dry eye disease. , 2012, Experimental eye research.

[41]  M. Petri,et al.  Autoimmune heart disease: role of sex hormones and autoantibodies in disease pathogenesis , 2012, Expert review of clinical immunology.

[42]  F. Wolfe,et al.  Fibromyalgia diagnosis and diagnostic criteria , 2011, Annals of medicine.

[43]  R. Thaler,et al.  Joint hypermobility syndrome: A common clinical disorder associated with migraine in women , 2011, Cephalalgia : an international journal of headache.

[44]  L. Padua,et al.  Ehlers–Danlos syndrome hypermobility type and the excess of affected females: Possible mechanisms and perspectives , 2010, American journal of medical genetics. Part A.

[45]  Herng‐Ching Lin,et al.  Comorbidities in Patients with Primary Sjögren’s Syndrome: A Registry-based Case-control Study , 2010, The Journal of Rheumatology.

[46]  J. Chiorini,et al.  Sjögren syndrome: advances in the pathogenesis from animal models. , 2009, Journal of autoimmunity.

[47]  TD Rozen,et al.  Cervical Spine Joint Hypermobility: A Possible Predisposing Factor for New Daily Persistent Headache , 2006, Cephalalgia : an international journal of headache.

[48]  J. Llobet,et al.  Are there clinical or serological differences between male and female patients with primary Sjögren's syndrome? , 2004, The Journal of rheumatology.

[49]  L. Jacobsson,et al.  Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? , 2000, Annals of the rheumatic diseases.

[50]  M. Weinstock.  A registry-based case-control study of mycosis fungoides. , 1991, Annals of epidemiology.